Clinical Trial Update: Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing docetaxel to observation after radical prostatectomy for prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Scandinavian Prostate Cancer Group | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN